| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
236,000,000 |
| Market
Cap: |
3.80(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.99 - $24.51 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1088 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
42,000 |
84,000 |
674,621 |
3,194,844 |
| Total Sell Value |
$751,590 |
$1,426,320 |
$13,510,369 |
$40,033,721 |
| Total People Sold |
1 |
1 |
4 |
7 |
| Total Sell Transactions |
2 |
4 |
17 |
31 |
| End Date |
2025-11-16 |
2025-08-15 |
2025-02-14 |
2024-02-15 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Salas Eduardo Rene |
|
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,690 |
21,579 |
|
- |
|
| Grossman Jerrold B |
|
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,690 |
488,884 |
|
- |
|
| Kwon Young |
|
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,690 |
263,020 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
282,529 |
2,290,379 |
|
- |
|
| Finger Alison Cecily |
|
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,690 |
45,619 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
91,631 |
580,321 |
|
- |
|
| Guiheen Lawrence P. |
|
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,690 |
105,520 |
|
- |
|
| Elms Steve |
|
• • – |
2026-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,690 |
98,020 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-12-15 |
4 |
AS |
$19.79 |
$415,590 |
D/D |
(21,000) |
2,007,850 |
|
-17% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-12-15 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,028,850 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-11-19 |
4 |
AS |
$16.00 |
$336,000 |
D/D |
(21,000) |
2,013,850 |
|
3% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-11-19 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,034,850 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-10-24 |
4 |
AS |
$16.00 |
$336,000 |
D/D |
(21,000) |
2,019,850 |
|
8% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-10-24 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,040,850 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-09-15 |
4 |
AS |
$16.13 |
$338,730 |
D/D |
(21,000) |
2,025,850 |
|
9% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-09-15 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,046,850 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-08-15 |
4 |
AS |
$16.88 |
$354,480 |
D/D |
(21,000) |
2,031,850 |
|
15% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-08-15 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,052,850 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2025-07-30 |
4 |
D |
$18.59 |
$22,457 |
D/D |
(1,208) |
488,690 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2025-07-30 |
4 |
OE |
$8.98 |
$22,450 |
D/D |
2,500 |
489,898 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2025-07-24 |
4 |
D |
$17.31 |
$52,397 |
D/D |
(3,027) |
487,398 |
|
- |
|
| Tade Brad L. |
CFO and Treasurer |
• • – |
2025-07-24 |
4 |
D |
$17.31 |
$123,299 |
D/D |
(7,123) |
239,419 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-07-15 |
4 |
AS |
$18.66 |
$391,860 |
D/D |
(21,000) |
2,037,850 |
|
-11% |
|
| Grossman Adam S |
President and CEO |
• • – |
2025-07-15 |
4 |
OE |
$5.40 |
$81,000 |
D/D |
15,000 |
2,058,850 |
|
- |
|
| Tade Brad L. |
CFO and Treasurer |
• • – |
2025-06-26 |
4 |
D |
$18.40 |
$181,019 |
D/D |
(9,838) |
246,542 |
|
- |
|
244 Records found
|
|
Page 1 of 10 |
|
|
0.50 (3.21%) 
